Gálvez-Acebal Muñoz

105 MONDAY SCIENTIFIC SESSIONS Final Program K-924 Successful Treatment of Simulated Clostridium difficile Infec- tion in a Human Gut Model by Fidaxomycin After Vancomycin or Metronidazole Failure C. H. Chilton 1 , G. Crowther 1 , J. Freeman 1 , S. Todhunter 1 , S. Nicholson 1 , C. Longshaw 2 , M. H. Wilcox 1 ; 1 Univ. of Leeds Leeds Teaching Hosp., Leeds, United Kingdom, 2 Astellas Phama Europe Ltd, Staines, United Kingdom. K-925 Clostridium difficile in Ready-to-Eat Raw Vegetables, France

C. Eckert

1,2 , B. Burghoffer 1,2 , F. Barbut 1,2 ; 1 Natl. Reference Lab. for C. difficile, Saint-Antoine Hosp., AP-HP, Paris, France, 2 UPMC Univ Paris 06, Paris, France. K-926 Procalcitonin Levels Correlate with Severity in Cases of Clostridium difficile Infection K. Rao, S. T. Walk, D. Micic, E. Chenoweth, L. Deng, MA Associate, R. Jain, I. Trivedi, M. Yu , C. Ring, V. B. Young , G. B. Huffnagle, D. M. Aronoff ; Univ. of Michigan, Ann Arbor, MI. K-927 Analysis of Sequential Isolates from Clostridium difficile Infec- tions by MLVA Subtyping

S. Taori

1,2 , A. Wroe 1 , K. Templeton 2 , A. Gibb 2 , I. Poxton 1 ; 1 Univ. of Ed- inburgh, Edinburgh, United Kingdom, 2 NHS Lothian, Edinburgh, United Kingdom. K-928 Evaluation of ATLAS Score in Predicting Clinical Cure and Recurrence of Clostridium difficile Infection CDI

S. Jacobson

1 , D. Slain 2 ; West Virginia Univ., Morgantown, WV. K-929 Do Antibiotic Combinations with Rifampin for Osteoarticular Infections Protect against Clostridium difficile-Associated Colitis? C. Landelle , M. Schindler , W. Zingg , L. Pagani , I. Uckay, D. Pittet; Univ. of Geneva Hosp., Geneva, Switzerland. K-930 Case-Control Study of Community-Onset Clostridium difficile Infections in the Netherlands

M. Hensgens

1 , A. Demeulemeester 2 , O. Dekkers 1 , A. Buiting 3 , P. Bloem- bergen 4 , B. van Benthem 5 , E. Kuijper 1 ; 1 LUMC, Leiden, Netherlands, 2 SHL, Breda, Netherlands, 3 Elisabeth Hosp., Tilburg, Netherlands, 4 Isala, Zwolle, Netherlands, 5 Natl. Inst. for Publ. Hlth. and the Environment, Bilthoven, Netherlands. K-931 Is There Any Correlation Between Microbiological Profile and the Prognosis of Clostridium difficile Disease CDD? D. Rodriguez-Pardo, B. Almirante, R. Bartolomé, J. Vila, B. Mirelis, F. March, T. Cornejo, M. Español, M. Lung, A. Pahissa; Barcelona Clostridium difficile Project Study Group, Barcelona, Spain. K-932 Risk Factors Predictive of Recurrent C. difficile Infection

P. Ty

1 , A. Wong-Beringer 2,1 ; 1 Huntington Hosp., Pasadena, CA, 2 Univ Southern California, Los Angeles, CA. K-933 Study on the Molecular Epidemiology and Antibiotic Resis- tance of Clostridium difficile Isolates in Shijiazhuang of China

J. Zhao

1 , J. Yang 1 , Y. Li 1 , S. Cui 2 , J. Li 1 , D. Shi 1 , W. Song 1 , H. Wei 1 , X. Liu 1 , C. Qiang 1 , Z. Li 1 , Q. Sun 1 ; 1 The Second Hosp. of Hebei Med. Univ., Shijianzhuang, Hebei Province, China, 2 Chinese Natl. Inst. for the Control of Pharmaceutical and Biological Products, Beijing, China. K-934 Comparison of Pulsed Xenon UV to Bleach for the Decontam- ination of

C. difficile from Surfaces in the Patient Environment

S. S. Ghantoji 1 , M. Stibich 2 , J. Stachowiak 2 , B. Tanner 3 , C. Perego 1 , S. Cantu 1 , R. F. Chemaly 1 ; 1 MD Anderson Cancer Ctr., Houston, TX, 2 Xenex Healthcare Services, LLC, San Antonio, TX, 3 Antimicrobial Test Lab., Austin, TX. K-935 Prevalence of Diarrhea Associated with Antibiotics Use in Two Concentration Hospitals in Mexico

R. Figueroa Infectious Disease Hosp., IMSS, Mexico, D.,F., Mexico.

K-936 MLST Analysis Investigation of 104 Clostridium difficile Isolates from Various Areas and Hospitals of China Y. Cheng, Q. Yan, H. Zhou, C. Chen, R. Cen, W. Li, J. Lu; State Key Lab. for Infectious Disease Prevention and Control, Natl. Inst. for Communi- cable Disease Control and Prevention, Chinese Ctr. for Disease Control and Prevention, Beijing, China. ------------------------------------------------------------------------ 106 K Poster Session Endocarditis Monday, 11:15 a.m.–1:15 p.m. . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: K-937 In-Hospital and Long-Term Outcome of Left-Sided Infective Endocarditis LSIE: The Influence of Methicillin-Resistant

S. aureus Infection on Prognosis

N. Fernández-Hidalgo, B. Almirante, P. Tornos, M. T. González-Alujas, A. M. Planes, M. Galiñanes, A. Pahissa; Hosp. Vall d’Hebron, Barcelona, Spain. K-938 Enterococcus faecalis Infective Endocarditis EFIE: The Influ- ence of Ampicillin + Gentamicin AG vs Ampicillin + Ceftriaxone AC on Outcome

N. Fernández-Hidalgo,

1,2 , B. Almirante 1,2 , J. Gavaldà 1,2 , M. Gurgui 2 , C. Peña 2 , A. de Alarcón 2 , J. Ruiz 2 , M. Montejo 2 , N. Vallejo 2 , I. Vilacosta 2 , F. López-Medrano 2 , A. Plata 2 , J. López 2 , C. Hidalgo 2 , J. Gálvez 2 , J. M. Lomas 2 , M. Falcone 3 , M. Noureddin 2 , X. Martínez-Lacasa 2 , A. Pahissa 1,2 ; 1 Hosp. Vall d’Hebron, Barcelona, Spain, 2 Enterococcus Faecalis Infective Endocarditis Study Group, Spain, 3 Enterococcus Faecalis Infective Endocarditis Study Group, Italy. K-939 Relationships Between Gender, Early Valve Surgery EVS and Mortality in Patients with Infective Endocarditis IE Analyzed in a Multicenter Cohort C. Chirouze, F. Alla, C. Selton-Suty, L. Schubel, T. Doco-Lecompte, M. Erpelding, X. Duval, B. Hoen; AEPEI, PARIS, France. K-940 The Clinical Impact of Routine Performance of PETCT in Patients with Infectious Endocarditis IE: Preliminary Results of a Prospective Ongoing Study M. Kestler, P. Muñoz, M. Rodriguez, F. Jimenez, A. Rotger, A. Marti, J. C. Alonso, J. Orcajo, E. Bouza; Hosp. G. U. Gregorio Marañon. Univ. of Madrid, Madrid, Spain. K-941 Influence of the Timing of Cardiac Surgery on the Prognosis of Left-Sided Native Endocarditis: Prospective and Multicenter Cohort study GAMES

J. Gálvez-Acebal

1 , P. Muñoz 2 , J. M. Miró 3 , A. Alarcón 4 , L. Castelo 5 , J. Ruiz 6 , A. Moreno 7 , M. Montejo 8 , J. Lomas 9 , S. Reus 10 , E. Bouza 11 , GAMES; 1 Hosp. VMacarena, Seville, Spain, 2 Hosp. GMarañón, Madrid, Spain, 3 Hosp. Clinic, Barcelona, Spain, 4 Hosp. VRocío, Seville, Spain, 5 Hosp. JCanalejo, Coruña, Spain, 6 Hosp. VVictoria, Malaga, Spain, 7 Hosp. La Paz, Madrid, Spain, 8 Hosp. Cruces, Bilbao, Spain, 9 Hosp. JRJimenez, Huelva, Spain, 10 Hosp. Alicante, Alicante, Spain, 11 Hosp. GMarañón, Seville, Spain. 106 SCIENTIFIC SESSIONS September 9-12 | K-942 Valve Surgery in Infective Endocarditis: Determinants of In-Hospital Prognosis M. Martinez-Selles 1 , A. Arnaiz 2 , P. Muñoz 1 , J. Ruiz 3 , M. Moreno 4 , J. Reguera 5 , J. Galvez 6 , J. Portu 7 , J. Oteo 8 , J. dela Torre 9 , E. Bouza- Prof 1 , GAMES; 1 H G.U. Gregorio Marañón. Univ. of Madrid, Madrid, Spain, 2 Hosp. Valdecilla, Santander, Spain, 3 Hosp. V Victoria, Málaga, Spain, 4 Hosp. La Paz, Madrid, Spain, 5 Hosp. Carlos Haya, Malaga, Spain, 6 Hosp. V Macarena, Seville, Spain, 7 Hosp. Txagorritxu, Barakaldo, Spain, 8 Hosp. San Pedro, La Rioja, Spain, 9 Hosp. Costa del Sol, Marbella, Spain. K-943 Short-Term and Long-Term Mortality Risk Factors in a Prospective Cohort of 1000 Consecutive Infective Endocarditis in Spain GAMES

P. Muñoz

1 , M. Fariñas 2 , A. Alarcón 3 , L. Castelo 4 , J. Miró 5 , M. Montejo 6 , E. Navas 7 , R. Ivanova 8 , J. Paño 9 , A. Moreno 10 , C. Hidalgo-Tenorio 11 , M. Goenaga 12 , A. Plata 13 , M. Rodríguez 1 , E. Bouza 1 , GAMES; 1 Hosp. G.U. Gregorio Marañón. Univ. of Madrid, Madrid, Spain, 2 Hosp. Valdecilla, Santander, Spain, 3 Hosp.V del Rocío, Sevilla, Spain, 4 Hosp. Juan Canalejo, Coruña, Spain, 5 Hosp. Clinic, Barcelona, Spain, 6 Hosp. Cruces, Bilbao, Spain, 7 Hosp. Ramón y Cajal, Madrid, Spain, 8 Hosp. V Victoria, Málaga, Spain, 9 Hosp. La Paz, Madrid, Spain, 10 Hosp. Central Asturias, Oviedo, Spain, 11 H V Nieves, Granada, Spain, 12 Hosp. Donosti, San Sebastián, Spain, 13 Hosp. Carlos Haya, Málaga, Spain. K-944 Efficacy of Daptomycin in the Treatment of Enterococcal Endocarditis: A 5-Year Perspective I. Ceron, P. Muñoz, M. Marin, M. Rodríguez-Créixems, B. Pinilla, A. Segado, J. Roda, H. Rodríguez, M. Valerio, A. Fernandez-Cruz, A. Burillo, E. Bouza- ID prof, GAME; Hosp. G.U. Gregorio Marañón, Univ. of Ma- drid, Madrid, Spain. K-945 Changes in the Antibiotic Treatment of Enterococcus faecalis Infective Endocarditis EF-IE in the Last 15 Years J. M. Pericas, C. Cervera, A. del Río, C. García-De-La-Maria, Ph , A. Moreno, X. Castañeda, M. Almela, C. Falces, S. Ninot, Y. Armero, C. A. Mestres, D. Soy, J. M. Gatell, F. Marco, J. M. Miró, Hospital Clinic Endo- carditis Study Group; Hosp. Clinic - IDIBAPS, Barcelona, Spain. K-946 Evaluation of Population Analysis Profile Susceptibility PAP as a Predictor of Patient Outcomes with Methicillin-Resistant Staphylococcus aureus MRSA Infective Endocarditis IE A. M. Casapao, S. Patel , R. Kullar, S. L. Davis, M. J. Rybak; Wayne State Univ., Anti-Infective Res. Lab., Detroit, MI. ------------------------------------------------------------------------ 107 K Poster Session Fungal Infections Monday, 11:15 a.m.–1:15 p.m. . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: K-947 Candidaemia in Malaysia: Surprising Results from a National Study

Q. A. Nguyen